Sheng Liu

2.9k total citations
132 papers, 1.8k citations indexed

About

Sheng Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sheng Liu has authored 132 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 37 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Sheng Liu's work include Cancer-related molecular mechanisms research (15 papers), Inflammatory mediators and NSAID effects (10 papers) and Bone health and treatments (8 papers). Sheng Liu is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), Inflammatory mediators and NSAID effects (10 papers) and Bone health and treatments (8 papers). Sheng Liu collaborates with scholars based in China, United States and Canada. Sheng Liu's co-authors include Chunyu Wu, Yiyi Ye, Xianghui Han, Zhenping Sun, Lisheng Wang, Sara El‐Sahli, Ying Xie, Feifei Li, Lixia Pei and Guoqing Liao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sheng Liu

124 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Liu China 24 960 393 380 222 188 132 1.8k
Ravi P. Sahu United States 25 1.2k 1.2× 416 1.1× 285 0.8× 293 1.3× 123 0.7× 89 2.2k
Yuan Qin China 26 1.2k 1.3× 420 1.1× 595 1.6× 258 1.2× 128 0.7× 120 2.2k
Qinghua Lu China 26 988 1.0× 282 0.7× 263 0.7× 206 0.9× 180 1.0× 70 1.9k
Hyun Ju Kang South Korea 27 757 0.8× 382 1.0× 271 0.7× 248 1.1× 175 0.9× 96 2.1k
Shan Deng China 26 1.1k 1.1× 488 1.2× 514 1.4× 241 1.1× 140 0.7× 71 2.0k
Chun‐Yin Huang Taiwan 30 1.2k 1.3× 463 1.2× 411 1.1× 321 1.4× 126 0.7× 60 2.2k
Chia-Wen Tsai Taiwan 23 1.0k 1.1× 434 1.1× 630 1.7× 194 0.9× 170 0.9× 140 2.1k
Wanyin Wu China 21 868 0.9× 405 1.0× 496 1.3× 200 0.9× 88 0.5× 49 1.6k
Yuanyuan Zhang China 28 927 1.0× 342 0.9× 249 0.7× 418 1.9× 126 0.7× 102 2.4k

Countries citing papers authored by Sheng Liu

Since Specialization
Citations

This map shows the geographic impact of Sheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Liu more than expected).

Fields of papers citing papers by Sheng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Liu. The network helps show where Sheng Liu may publish in the future.

Co-authorship network of co-authors of Sheng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Liu. A scholar is included among the top collaborators of Sheng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Liu. Sheng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yi, Chunyu Wu, Jiajing Chen, et al.. (2024). OSU-T315 overcomes immunosuppression in triple-negative breast cancer by targeting the ILK/NF-κB signaling pathway to enhance immunotherapeutic efficacy. International Immunopharmacology. 143(Pt 3). 113530–113530. 1 indexed citations
2.
Liu, Sheng, et al.. (2024). Is mechanical bowel preparation mandatory for elective colon surgery? A systematic review and meta-analysis. Langenbeck s Archives of Surgery. 409(1). 99–99.
3.
Wang, Xuyan, et al.. (2024). Exploring the Biomedical Potential of Terpenoid Alkaloids: Sources, Structures, and Activities. Molecules. 29(9). 1968–1968. 6 indexed citations
5.
Zhang, Jin-Xing, Jin Liu, Sheng Liu, et al.. (2024). Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study. Journal of Hepatocellular Carcinoma. Volume 11. 1993–2003. 3 indexed citations
6.
Zhu, Mengjiao, Yiwen Zhou, Xiao Liu, et al.. (2023). Coordination effect enhanced visualization of latent fingerprint with Eu (TTA)3phen-SiO2 microspheres. Analytica Chimica Acta. 1279. 341774–341774. 10 indexed citations
8.
Wang, Ge, et al.. (2023). Research on Anti-inflammatory Targets and Mechanisms of alkaloids in Picrasma quassioides Benn Through Network Pharmacology. Brazilian Journal of Pharmaceutical Sciences. 59. 1 indexed citations
9.
Zhang, Manling, Ruchao Peng, Qi Peng, et al.. (2023). Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage. Proceedings of the National Academy of Sciences. 120(18). e2215098120–e2215098120. 3 indexed citations
10.
Wu, Chunyu, Guang‐Yu Liu, Xiaohong Xue, et al.. (2022). Effectiveness of the Sanyin Formula Plus Chemotherapy on Survival in Women With Triple-Negative Breast Cancer: A Randomized Controlled Trial. Frontiers in Oncology. 12. 850155–850155. 4 indexed citations
11.
Wu, Yuanyuan, Feifei Li, Yang Zhang, et al.. (2022). Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: Coupling network pharmacology with experimental validation. Journal of Ethnopharmacology. 293. 115326–115326. 8 indexed citations
12.
Wang, Yan, Haiyang Liu, Zhekun Shi, et al.. (2022). A responsive hydrogel-based microneedle system for minimally invasive glucose monitoring. SHILAP Revista de lepidopterología. 4. 69–77. 38 indexed citations
13.
Song, Haiyan, Zhong-Yan Zhou, Jiao Ma, et al.. (2021). Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITGα3/ITGβ5 signaling. Acta Pharmacologica Sinica. 43(6). 1544–1555. 21 indexed citations
14.
Liu, Peng, et al.. (2020). <p>Skin Metastasis of Gastrointestinal Stromal Tumors: A Case Series and Literature Review</p>. Cancer Management and Research. Volume 12. 7681–7690. 5 indexed citations
15.
Peng, Yizhong, Donghua Huang, Sheng Liu, et al.. (2020). Biomaterials-Induced Stem Cells Specific Differentiation Into Intervertebral Disc Lineage Cells. Frontiers in Bioengineering and Biotechnology. 8. 56–56. 17 indexed citations
16.
Liu, Sheng. (2012). NMR studies of RNA binding domains of human lysyl aminoacyl tRNA synthetase. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations
17.
Li, Qiong & Sheng Liu. (2010). Inhibition of Bone Metastasis of Breast Cancer by Fructus Psoraleae and Fructus Cnidii in vivo. 1 indexed citations
19.
Lü, Shuanghong, Sheng Liu, Wenjun He, et al.. (2008). Bioreactor Cultivation Enhances NTEB Formation and Differentiation of NTES Cells into Cardiomyocytes. Cloning and Stem Cells. 10(3). 363–370. 21 indexed citations
20.
Liu, Sheng, et al.. (2003). Therapeutic Effect and Thinking of Mammary Cancer Treated by Chinese Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026